At the 2025 Summer Davos Forum in Tianjin, Synchron CEO Tom Oxley highlighted China's rapid progress in brain-computer interface (BCI) technology, calling it a 'global frontrunner' in developing next-generation neurotech solutions. The U.S.-based BCI pioneer emphasized China's strategic investments and cross-sector collaborations as key drivers of innovation.
China's BCI Momentum
Oxley noted that Chinese research institutions and tech firms are achieving 'unprecedented milestones' in non-invasive neural interfaces, with clinical trials progressing faster than in Western markets. 'The speed at which regulatory approvals and ethical reviews are handled here enables quicker translation from lab to real-world applications,' he told CGTN.
Beyond Medical Applications
While acknowledging BCI's healthcare potential for treating neurological disorders, Oxley revealed discussions about consumer applications during Synchron's recent collaboration with Apple. 'The synergy between BCI and AI could redefine human-computer interaction within this decade,' he said, pointing to emerging R&D partnerships across Asia.
Global Tech Race Intensifies
Analysts suggest China's BCI advancements could influence global standards for neurotechnology. The Chinese mainland's focus on integrating BCI with smart manufacturing and education systems aligns with its broader AI development goals, creating new opportunities for international investors and tech firms.
